S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
Log in
NASDAQ:PAHC

Phibro Animal Health Stock Forecast, Price & News

$17.36
-0.48 (-2.69 %)
(As of 09/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$17.23
Now: $17.36
$18.07
50-Day Range
$17.54
MA: $19.26
$21.59
52-Week Range
$16.87
Now: $17.36
$29.38
Volume78,467 shs
Average Volume157,385 shs
Market Capitalization$702.26 million
P/E Ratio21.17
Dividend Yield2.69%
Beta0.33
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Israel, Latin America, Canada, Europe, Africa, and the Asia/Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. The company is headquartered in Teaneck, New Jersey. Phibro Animal Health Corporation is a subsidiary of BFI Co., LLC.
Read More
Phibro Animal Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.99 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$800.40 million
Cash Flow$1.82 per share
Book Value$4.65 per share

Profitability

Net Income$33.55 million

Miscellaneous

Employees2,500
Market Cap$702.26 million
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$17.36
-0.48 (-2.69 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

How has Phibro Animal Health's stock been impacted by COVID-19 (Coronavirus)?

Phibro Animal Health's stock was trading at $24.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PAHC shares have decreased by 29.4% and is now trading at $17.36.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Phibro Animal Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Phibro Animal Health
.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Phibro Animal Health
.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) issued its quarterly earnings data on Wednesday, August, 26th. The company reported $0.17 EPS for the quarter, missing the Zacks' consensus estimate of $0.22 by $0.05. The business earned $185.90 million during the quarter. Phibro Animal Health had a return on equity of 21.69% and a net margin of 4.19%.
View Phibro Animal Health's earnings history
.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Monday, July 27th. Shareholders of record on Wednesday, September 2nd will be given a dividend of $0.12 per share on Wednesday, September 23rd. This represents a $0.48 annualized dividend and a dividend yield of 2.76%. The ex-dividend date of this dividend is Tuesday, September 1st.
View Phibro Animal Health's dividend history
.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health updated its first quarter 2021 After-Hours earnings guidance on Wednesday, August, 26th. The company provided earnings per share (EPS) guidance of 0.18-0.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.26. The company issued revenue guidance of $190-190 million, compared to the consensus revenue estimate of $189.49 million.

What price target have analysts set for PAHC?

5 Wall Street analysts have issued 12-month price targets for Phibro Animal Health's stock. Their forecasts range from $20.00 to $30.00. On average, they expect Phibro Animal Health's share price to reach $24.00 in the next year. This suggests a possible upside of 38.2% from the stock's current price.
View analysts' price targets for Phibro Animal Health
.

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 989,300 shares, an increase of 12.7% from the August 15th total of 878,100 shares. Based on an average daily trading volume, of 126,000 shares, the short-interest ratio is presently 7.9 days. Approximately 4.9% of the shares of the stock are short sold.
View Phibro Animal Health's Short Interest
.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the following people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $17.36.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $702.26 million and generates $800.40 million in revenue each year. The company earns $33.55 million in net income (profit) each year or $1.08 on an earnings per share basis. Phibro Animal Health employs 2,500 workers across the globe.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is www.pahc.com.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.